Sio Gene Therapies Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SIOX research report →
Companywww.siogtx.com
Sio Gene Therapies Inc. , a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd.
- CEO
- David W. Nassif
- IPO
- 2015
- Employees
- 12
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- -0.49
- P/S
- 0.00
- P/B
- 0.58
- EV/EBITDA
- 0.86
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -78.26%
- ROIC
- -114.96%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-71,887,000 · -121.70%
- EPS
- $-0.98 · -58.06%
- Op Income
- $-72,267,000
- FCF YoY
- -29.91%
Performance & Tape
- 52W High
- $0.50
- 52W Low
- $0.25
- 50D MA
- $0.39
- 200D MA
- $0.39
- Beta
- 1.08
- Avg Volume
- 62.41K
Get TickerSpark's AI analysis on SIOX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 8, 22 | Meswani Parag V | other | 153,700 |
| Feb 8, 22 | Nassif David W. | other | 546,500 |
| Jan 28, 22 | Meswani Parag V | other | 0 |
| Jan 28, 22 | Meswani Parag V | other | 15,625 |
| Jan 28, 22 | Meswani Parag V | other | 12,500 |
| Jan 28, 22 | Meswani Parag V | other | 8,033 |
| Jan 28, 22 | Meswani Parag V | other | 18,075 |
| Jan 28, 22 | Meswani Parag V | other | 219,000 |
| Dec 8, 21 | Nassif David W. | other | 17,534 |
| Dec 8, 21 | Nassif David W. | other | 6,294 |
Our SIOX Coverage
We haven't published any research on SIOX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SIOX Report →